ArticleJournal of cancer research and clinical oncology2018

Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR.

Daniele Generali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.